Taj Pharma As a Health Care Provider
Taj Pharma is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. We have eight manufacturing sites under flagship in India to support our market standing. Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
Today, we market more than 100+ branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.
At Taj Pharma, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian countries.
Our Generics portfolio offers over 600+ products in the major therapeutic areas of gastro-intestinal, cardiovascular, pain management, oncology, anti-infectives, paediatrics and dermatology. Brands like Alzocum®, Benacof, Wallbrurate®, Coversec, Cadrol, Humogen and Merokem enjoy leadership positions in several key markets, including India, Russia & other CIS countries.
Our deep customer relationships, quality medicines and consistently delivered promise make us a trusted brand across the launched markets.
We have capitalized on every opportunity to bring our high-quality products to more people around the globe. A synchronized supply chain that leverages our strong product development capabilities, state-of-the-art manufacturing setups and vertical integration with our own APIs has created a creditable track record of successful launches.
Our generics offerings deliver quality at cost-effective prices in the semi-regulated markets of the South America, North America, Africa, Balkan countries & Asian
Click here for Download pdf of patient informationClick here for Download pdf of prescribing information
Our Partners
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.Taj Pahrma India.
Important Safety Information
Allergy warning
Beprin can cause a severe allergic reaction. Symptoms can include: skin tissue death at the injection site, chills, fever, rash, hives, itching, burning, shortness of breath, swelling of your face, lips, throat, or tongue If you develop these symptoms, go to the nearest emergency room.
Don’t take this drug again if you’ve ever had an allergic reaction to it. Beprin is derived from animal tissue. It should be used with caution in people with a history of allergy to this drug or to pig proteins. Taking beprin could be fatal (cause death).
Warnings for people with certain health conditions
For people with pig protein sensitivity: Do not take this drug. This drug is made from pork tissue and can cause a life-threatening allergic reaction in people who are sensitive or allergic to other pig proteins.
For people with uncontrolled high blood pressure: You are at an increased risk of bleeding from this drug. Talk to your doctor before using beprin.
For people with bleeding or clotting problems: If you have abnormal bleeding or a condition that puts you at an increased risk of bleeding, using beprin could increase your risk even more. Use Beprin with caution.
For people with a history of stomach ulcers or bleeding: If you have active stomach ulcers, you should not use beprin. It could make your ulcers worse and cause dangerous bleeding. If you have a history of stomach ulcers but don’t have active ulcers, using beprin puts you at an increased risk of bleeding. You should talk to your doctor before using beprin.
For people with kidney disease: If you have severe kidney disease or a history of kidney disease, taking beprin can increase your risk of bleeding. Talk to your doctor before using beprin.
For people with liver disease: If you have severe liver disease or a history of liver disease, taking beprin can increase your risk of bleeding. Talk to your doctor before using beprin.
For people with asthma or sulfite sensitivity: People with asthma are likely to be sensitive to sulfites. Sulfites can cause a life-threatening allergic reaction in some people. Some forms of this drug contain sulfites. Talk to your doctor about using a sulfite-free version of beprin.
Warnings for other groups
For pregnant women: Research in animals has shown negative effects to the fetus when the mother uses beprin. However, there haven’t been enough studies done in humans to be certain how the drug might affect the fetus. Talk to your doctor if you’re pregnant or plan to become pregnant. This drug should only be used if the potential benefit justifies the potential risk. Ask your doctor if using the preservative-free version of beprin would be better for you than the version that contains benzyl alcohol. If you become pregnant while taking this drug, call your doctor right away.
For women who are breastfeeding: Beprin is unlikely to pass into breast milk and be absorbed by an infant who is breastfed. Talk to your doctor about the best way to feed your child while you’re taking beprin. Some forms of beprin contain a preservative called benzyl alcohol. This ingredient can slow down the central nervous system in some infants. It has also caused trouble breathing and changes in the blood chemistry in some infants. These effects can be deadly. If you breastfeed your child, talk to your doctor about preservative-free beprin.
For seniors: If you are older than 60 years, you may be at a higher risk of bleeding. Beprin also increases your risk of bleeding, so your doctor may start you on a reduced dosage.
For children: This medication has not been studied in children. Dosage recommendations are based on clinical experience. Newborns and infants should receive preservative-free beprin. The preservative benzyl alcohol has been linked to serious side effects and even death in newborns and infants.